FREMONT, Calif., June 13 /PRNewswire-FirstCall/ -- PDL BioPharma, Inc.
(PDL) (Nasdaq: PDLI) today announced that the company will participate in
the upcoming William Blair 27th Annual Growth Stock Conference in Chicago
on Thursday, June 21, 2007, at 3:50 p.m. Central time.
The live webcast of the presentation will be available through the PDL
website: http://www.pdl.com. Please connect to this website at least 15
minutes prior to the live webcast to allow time for any software download
that may be needed to hear the webcast. A replay will be available at
http://www.pdl.com starting approximately one hour after completion of the
webcast.
About PDL BioPharma
PDL BioPharma, Inc. is a biopharmaceutical company focused on
discovering, developing and commercializing innovative therapies for severe
or life-threatening illnesses. Commercially focused in the acute-care
hospital setting, PDL markets and sells its portfolio of commercial
products in the United States and Canada. A pioneer of antibody
humanization technology, PDL promotes this technology through licensing
agreements and clinical development of its own diverse pipeline of
investigational compounds. PDL's research platform centers on the discovery
and development of antibodies to treat cancer and autoimmune diseases. For
more information, please visit http://www.pdl.com.
NOTE: PDL BioPharma and the PDL logo are considered trademarks of PDL
BioPharma, Inc.
SOURCE PDL BioPharma, Inc.
 back to top
Related links:
http://www.pdl.com
CONTACT:
Ami Knoefler, Corporate and Investor
Relations, +1-510-284-8851, ami.knoefler@pdl.com, or Jean Suzuki,
Investor Relations, +1-510-574-1550, jean.suzuki@pdl.com, both of
PDL BioPharma, Inc.
|
